PAA 0.00% 19.5¢ pharmaust limited

Ann: Appendix 4C - Quarterly Report & Brief Company Update, page-29

  1. 2,383 Posts.
    lightbulb Created with Sketch. 1473
    The time frame would have to be uncertain because Juniper only had partial success after a lot of work. At least it was sufficient to enable some preliminary trials, but for the time and money spent, a big let down. Poor palatability restricts dosage, which restricts effectiveness, and therefore restricts full trial testing, so they're all interlinked, unfortunately.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.000(0.00%)
Mkt cap ! $86.55M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $330.4K 1.741M

Buyers (Bids)

No. Vol. Price($)
1 4071 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 24580 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.